Immix Biopharma (IMMX)
(Delayed Data from NSDQ)
$1.89 USD
-0.02 (-1.05%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $1.88 -0.01 (-0.53%) 6:04 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | 28.57% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.88 |
Next Year | -0.84 |
EPS (TTM) | -0.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.19 | -0.88 | -0.84 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.21 | -0.19 | -0.93 | -1.01 |
High Estimate | -0.21 | -0.19 | -0.83 | -0.67 |
Low Estimate | -0.21 | -0.19 | -0.93 | -1.01 |
Year ago EPS | -0.23 | -0.24 | -0.89 | -0.88 |
Year over Year Growth Est. | 8.70% | 20.83% | 1.12% | 4.55% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.19 | -0.88 | -0.84 |
7 Days Ago | -0.21 | -0.19 | -0.88 | -0.84 |
30 Days Ago | -0.21 | -0.19 | -0.88 | -0.84 |
60 Days Ago | -0.22 | -0.22 | -0.91 | -0.95 |
90 Days Ago | -0.22 | -0.22 | -0.91 | -0.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.19 | -0.88 | -0.84 |
Zacks Consensus Estimate | -0.21 | -0.19 | -0.88 | -0.84 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.22 | -0.24 | -0.23 | NA |
Estimate | -0.21 | -0.23 | -0.23 | -0.23 | NA |
Difference | 0.06 | 0.01 | -0.01 | 0.00 | 0.02 |
Surprise | 28.57% | 4.35% | -4.35% | 0.00% | 7.14% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more